Insights

Targeted CNS models AxoSim is actively expanding CNS- focused platforms with CNS-3D Alzheimer's Model and CNS-3D Myelinated Organoids, indicating an opportunity to position advanced organoid assays for neurodegenerative drug discovery and safety profiling.

Clinical liability focus The company plans to present data on predicting seizure liability using human CNS-3D Brain Organoids, suggesting demand for assays that de-risk small molecule programs and help comply with CNS safety requirements.

Neurotechnology leadership With the Nexon neurotechnology platform integrating tissue engineering, neural interfacing, and AI, there is potential to cross-sell research services, data analytics, and collaboration on human brain models to larger pharma and biotech customers.

Louisiana expansion Recent announcements in Louisiana signal a regional go-to-market hub; target local CROs, academic partnerships, and regional pharma ventures that could leverage nearby regulatory and translational opportunities.

Funding and scale Current revenue under one million with modest funding suggests a need for strategic partnerships and grant-assisted projects; propose pilot programs and co-development deals to accelerate scale and demonstrate ROI to mid-sized biotech firms.

Similar companies to AxoSim

AxoSim Tech Stack

AxoSim uses 8 technology products and services including Google Ads, LinkedIn Ads, iCIMS, and more. Explore AxoSim's tech stack below.

Media & News

AxoSim's Email Address Formats

AxoSim uses at least 4 email formats:
AxoSim Email FormatsExamplePercentage
First.Last@axosim.comJohn.Doe@axosim.com
91%
First.M.Last@axosim.comJohn.M.Doe@axosim.com
7%
Fir.Last@axosim.comJoh.Doe@axosim.com
2%
First.Last@28bio.comJohn.Doe@28bio.com
100%

Frequently Asked Questions

What is AxoSim's phone number?

Minus sign iconPlus sign icon
You can contact AxoSim's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AxoSim's official website and social media links?

Minus sign iconPlus sign icon
AxoSim's official website is 28bio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does AxoSim generate?

Minus sign iconPlus sign icon
As of October 2026, AxoSim's annual revenue is estimated to be <$1M.

What is AxoSim's SIC code and NAICS code?

Minus sign iconPlus sign icon
AxoSim's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AxoSim have currently?

Minus sign iconPlus sign icon
As of October 2026, AxoSim has approximately 5 employees across 1 continents, including North America. Key team members include Chief Executive Officer: L. C. Explore AxoSim's employee directory with LeadIQ.

What industry does AxoSim belong to?

Minus sign iconPlus sign icon
AxoSim operates in the Biotechnology Research industry.

What technology does AxoSim use?

Minus sign iconPlus sign icon
AxoSim's tech stack includes Google Ads, LinkedIn Ads, iCIMS, Salesforce, Microsoft 365, Marketo, Webflow and Piwik PRO Core.

What is AxoSim's email format?

Minus sign iconPlus sign icon
AxoSim's email format typically follows the pattern of First.Last@axosim.com. Find more AxoSim email formats with LeadIQ.

How much funding has AxoSim raised to date?

Minus sign iconPlus sign icon
As of October 2026, AxoSim has raised $225K in funding. The last funding round occurred on Jul 24, 2025 for $1.8M.

When was AxoSim founded?

Minus sign iconPlus sign icon
AxoSim was founded in 2014.
AxoSim logo

AxoSim

Biotechnology ResearchLouisiana, United States2-10 Employees

AxoSim is a biotechnology research company based in New Orleans, Louisiana. The organization is described as operating with a small team and sits within the biotechnology research sector, focusing on scientific work in that field. In its ecosystem, StemoniX is listed as a related company that AxoSim has acquired, illustrating corporate development within the broader industry. 

The provided materials also place AxoSim among a broader peer group in biotechnology research, highlighting the competitive landscape in this space. The available information does not specify AxoSim's exact products or services.

Section iconCompany Overview

Phone number
Website
28bio.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
2-10

Section iconFunding & Financials

  • $225K

    AxoSim has raised a total of $225K of funding over 2 rounds. Their latest funding round was raised on Jul 24, 2025 in the amount of $1.8M.

  • <$1M

    AxoSim's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.